Tirzepatide

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, representing a novel class of incretin-based research compounds. It has been the subject of extensive preclinical and clinical research, making it one of the most studied dual agonist peptides in the modern pharmacological literature.

Researchers have investigated Tirzepatide across a broad range of in vitro and in vivo models, with an extensive body of published clinical trial data examining its simultaneous activation of both GIP and GLP-1 receptors and its role in glycaemic regulation and type 2 diabetes management. Of particular interest to researchers is Tirzepatide’s dual agonist mechanism, which has been shown in published clinical trials to produce distinct metabolic effects compared to selective GLP-1 receptor agonists alone. Published research has further examined Tirzepatide in models relating to body weight modulation, insulin sensitivity, cardiovascular outcomes, and non-alcoholic fatty liver disease pathways.

Ambros Labs supplies Tirzepatide to qualified researchers across Canada from our Canadian inventory. Every batch is independently tested by a third-party Canadian laboratory using HPLC and mass spectrometry, with verifiable Certificates of Analysis available for every batch. All orders ship same-day from Canada with full chain of custody documentation.

For research use only. Not for human or veterinary use. For use by qualified researchers in appropriate laboratory settings only.

CAS Number: 2023788-19-2

Molecular Weight (g/moL): 4813.45

Molecular Formula: C225H348N48O68

Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS

Format: White Lyophilized Powder

Database Link